ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
63,336.20
-1.04%
S&P 500
5,180.74
1.03%
Dow Jones
38,852.27
0.46%
US Dollar vs Yen
153.919
0.23%
Brent Oil
83.395
0.32%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Celgene Corporation (CELG)

  7. Celgene Corporation (CELG) ニュース

CELG

Celgene (CELG)

Celgene Corporation
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:CELG
日付受信時刻ニュースソース見出しコード企業名
2019/12/1621 : 30GlobeNewswire Inc.NexImmune Appoints Sol Barer as Chairman of the Board of DirectorsNASDAQ:CELGCelgene Corporation
2019/11/2120 : 21PR Newswire (US)Amgen Completes Acquisition Of Otezla® (apremilast)NASDAQ:CELGCelgene Corporation
2019/11/2106 : 18Business WireCelgene Announces Plans to Transfer Listing of Celgene’s Contingent Value Rights Following Closing of Acquisition by Bristo...NASDAQ:CELGCelgene Corporation
2019/11/2104 : 09Business WireCELGENE ERHÄLT DIE ZULASSUNGSEMPFEHLUNG DES CHMP FÜR LENALIDOMID (REVLIMID®) IN KOMBINATION MIT RITUXIMAB ZUR BEHANDLUNG V...NASDAQ:CELGCelgene Corporation
2019/11/2001 : 16PR Newswire (US)Thermo Fisher Scientific Set to Join S&P 100; ServiceNow to Join S&P 500NASDAQ:CELGCelgene Corporation
2019/11/1907 : 10GlobeNewswire Inc.Exelon Corporation to Join the NASDAQ-100 Index Beginning November 21, 2019NASDAQ:CELGCelgene Corporation
2019/11/1607 : 39Dow Jones NewsFTC Requires Bristol-Meyers Squibb, Celgene to Divest Otezla as Condition of AcquisitionNASDAQ:CELGCelgene Corporation
2019/11/1522 : 22Dow Jones NewsCelgene Gets CHMP Positive Opinion for Revlimid/Rituximab Combo in Follicular LymphomaNASDAQ:CELGCelgene Corporation
2019/11/1521 : 30Business WireCelgene Receives CHMP Positive Opinion for REVLIMID® (lenalidomide) in Combination With Rituximab for the Treatment of Adult...NASDAQ:CELGCelgene Corporation
2019/11/1312 : 28PR Newswire (Canada)Skyhawk Therapeutics annonce une deuxième entente de collaboration multicible avec Celgene pour découvrir et mettre au poin...NASDAQ:CELGCelgene Corporation
2019/11/1223 : 00PR Newswire (US)Skyhawk Therapeutics Announces a Second Multi-Target Collaboration Agreement with Celgene to Discover and Develop Novel Small...NASDAQ:CELGCelgene Corporation
2019/11/1223 : 00PR Newswire (Canada)Skyhawk Therapeutics Announces a Second Multi-Target Collaboration Agreement with Celgene to Discover and Develop Novel Small...NASDAQ:CELGCelgene Corporation
2019/11/0903 : 30Dow Jones NewsAcceleron Pharma Shares Gain Ground After FDA Approves ReblozylNASDAQ:CELGCelgene Corporation
2019/11/0903 : 20Dow Jones NewsFDA Approves Celgene's and Acceleron's Reblozyl to Treat Rare Blood DisorderNASDAQ:CELGCelgene Corporation
2019/11/0902 : 33Business WireFDA Approves REBLOZYL® (luspatercept-aamt) for the Treatment of Anemia in Adults With Beta Thalassemia Who Require Regular R...NASDAQ:CELGCelgene Corporation
2019/11/0706 : 06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
2019/11/0623 : 06Business WireCelgene to Present New & Updated Data on Key Hematology Pipeline Therapies at American Society of Hematology (ASH) 2019 Annua...NASDAQ:CELGCelgene Corporation
2019/11/0506 : 21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
2019/11/0506 : 19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
2019/11/0506 : 16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
2019/11/0506 : 16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
2019/11/0506 : 10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
2019/11/0105 : 05Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CELGCelgene Corporation
2019/10/3120 : 37Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CELGCelgene Corporation
2019/10/3120 : 30Business WireCelgene Reports Third Quarter 2019 Operating and Financial ResultsNASDAQ:CELGCelgene Corporation
2019/10/1619 : 00Business WireCelgene & the Multiple Sclerosis Association of America Take the MS MindShift Initiative & “Brain Bulb” Hot Air Balloon t...NASDAQ:CELGCelgene Corporation
2019/09/2020 : 30Business WireCelgene Corporation Names Second Round of Celgene Cancer Care Links™ Program Grant RecipientsNASDAQ:CELGCelgene Corporation
2019/09/2005 : 06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
2019/09/1305 : 30Business WireCelgene Announces Phase 3 QUAZAR® AML-001 Study of CC-486 as Maintenance Therapy in Patients With Newly Diagnosed Acute Myel...NASDAQ:CELGCelgene Corporation
2019/09/1201 : 24Dow Jones NewsSwiss Biotech Anokion Raises $40 Million in Series B RoundNASDAQ:CELGCelgene Corporation
 Showing the most relevant articles for your search:NASDAQ:CELG

最近閲覧した銘柄

FX
USDJPY
US Dollar vs Yen
COIN
BTCUSD
Bitcoin
NYSE
XOM
Exxon Mobil
USOTC
BNPQY
BNP Paribas (QX)
NYSE
JPM
JP Morgan Chase
NASDAQ
GOOGL
Alphabet
AMEX
XLV
Health Care Select Sector
NYSE
MCD
McDonalds
NASDAQ
TSLA
Tesla
CCOM
SILVER
SILVER
FX
USDGBP
US Dollar vs Sterling
USOTC
ADDYY
Adidas (QX)
NYSE
CVX
Chevron
NASDAQ
MSFT
Microsoft
USOTC
DTEGY
Deutsche Telekom (QX)
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有